Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

Once confined to Latin America, Chagas disease – a potentially deadly parasitic infection that is spread in a gross way – is ...

Mycoplasma infection acts as an invisible killer in the biopharmaceutical industry, compromising drug safety and patient health on a continuous basis. As the industry progresses, mycoplasma testing ...

Durvalumab is currently approved for a number of cancer types. Though not approved in gastric cancer, the MATTERHORN regimen ...

Early in the coronavirus pandemic, U.S. President Donald Trump put his faith in a toaster-sized machine that could spit out test results in a matter of minutes.

Tata Capital enters the market while navigating a phase of margin compression. While analysts expect profitability to recover ...

Feeling sick at sea? Learn what to do right away, from alerting the ship's doctor to managing your symptoms and preventing an ...

Baystreet.ca News Commentary – Major biotechnology companies are presenting multi-cancer detection data and breakthrough clinical results at the European Society for Medical Oncology ...

Gilbert & George: 21st Century Pictures, a panoramic and sometimes immersive survey of the duo’s output from the last quarter ...

The gap widens when girls internalize the belief that STEM is for the chosen few and never for them. Breaking the illusion is ...

Tata Capital's CEO discusses the upcoming IPO, a significant event for the year. The company set the share price to allow wide investor participation. Proceeds will augment Tier-1 capital. This ...

Regulatory burdens have raised the capital requirements for early-stage companies, causing many to do what would have been ...